Corcept Therapeutics (HTD) Q1 2021 Earnings Report
CH:HTD Q1 2021 EPS Results
- Actual EPS
- CHF 0.15
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- CHF 0.21
CH:HTD Q1 2021 Revenue Results
- Actual Revenue
- CHF 65.44M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -14.81%
Earnings Announcement Details
- Quarter
- Q1 2021
- Date
- 05/06/2021
- Time
- After Close
- Conference Call
- Thursday, May 6, 2021
CH:HTD Upcoming Earnings
Corcept Therapeutics's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q1 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:HTD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | 0.65- | 0.13 | ― | ― |
| Jul 29, 2026 | 2026 (Q2) | 0.020.30 | 0.24 | 24.14% (+0.06) | |
| Apr 30, 2026 | 2026 (Q1) | -0.09-0.25 | 0.14 | -276.47% (-0.39) | |
| Feb 24, 2026 | 2025 (Q4) | 0.270.16 | 0.21 | -23.08% (-0.05) | |
| Nov 04, 2025 | 2025 (Q3) | 0.140.13 | 0.34 | -60.98% (-0.21) | |
| Jul 31, 2025 | 2025 (Q2) | 0.150.24 | 0.26 | -9.38% (-0.02) | |
| May 05, 2025 | 2025 (Q1) | 0.120.14 | 0.21 | -32.00% (-0.07) | |
| Feb 26, 2025 | 2024 (Q4) | 0.350.21 | 0.23 | -7.14% (-0.02) | |
| Oct 30, 2024 | 2024 (Q3) | 0.230.34 | 0.23 | 46.43% (+0.11) | |
| Jul 29, 2024 | 2024 (Q2) | 0.190.26 | 0.21 | 28.00% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed